Related Experiment Video
Updated: Aug 5, 2026
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Diagnostic value of quantitative MR spectroscopy metabolite ratios for Canavan disease
Majid Reza Tahsini1, Marzena Wylezinska-Arridge2, Mohammad Zare3
1Haghighat medical imaging research center, Haghighat medical imaging center, Tehran, Iran.
Purpose:
Canavan disease (CD) is a leukodystrophy marked by deficiency in the aspartoacylase enzyme and accumulation of N-acetyl aspartate (NAA) in the white matter. MRI and MRS are crucial diagnostic tools for CD. MRS shows a distinctive, significant elevation of the NAA peak, which is typically not quantified and thus not objectively assessed as a diagnostic criterion. This study aimed to establish quantitative cutoff values for the elevated NAA peak on proton MR spectroscopy (1H-MRS) in patients with CD and hence, incorporate MRS into the diagnostic algorithm.
Methods:
A cross-sectional retrospective diagnostic study involving 18 confirmed CD cases and 10 healthy individuals was conducted to assess metabolic profiles and determine a diagnostic cutoff for NAA in CD. 1H MRS (TE: 135 ms) was utilized, and data were post-processed using specialized software to quantify the ratios of the three primary metabolites: NAA, Cho, and Cr.
Results:
The analysis of the CD cases demonstrated substantial elevation in NAA levels compared to the standard control group with the NAA/Cr and NAA/Cho ratios significantly increased in CD patients compared to controls (p < 0.001 for both). Diagnostic cut-off values of 2.75 for NAA/Cr and 7.18 for NAA/Cho yielded an optimism-corrected AUC = 0.96 (95% CI 0.95-1.00) after bootstrap validation.
Conclusion:
This study represents one of the larger single-center cohorts evaluating quantitative MRS metabolite ratios in Canavan disease and proposes preliminary diagnostic thresholds for improved diagnostic objectivity.
Insights
Canavan disease diagnosis is improved by quantifying N-acetyl aspartate (NAA) levels using magnetic resonance spectroscopy (MRS). This study establishes quantitative thresholds for NAA/Cr and NAA/Cho ratios, enhancing diagnostic objectivity for this rare leukodystrophy.
Area of Science:
- Biochemistry
- Neurology
- Medical Imaging
Background:
- Canavan disease (CD) is a rare genetic leukodystrophy characterized by aspartoacylase deficiency and N-acetyl aspartate (NAA) accumulation in white matter.
- Magnetic Resonance Spectroscopy (MRS) detects elevated NAA in CD, but lacks standardized quantitative criteria for diagnosis.
- Objective assessment of NAA levels is crucial for integrating MRS into the diagnostic algorithm for Canavan disease.
Purpose of the Study:
- To establish quantitative cutoff values for elevated NAA on proton MRS (¹H-MRS) in Canavan disease patients.
- To enhance the diagnostic objectivity of MRS for Canavan disease by defining specific metabolite ratios.
- To potentially incorporate quantitative MRS findings into the diagnostic algorithm for Canavan disease.
Main Methods:
- A retrospective diagnostic study included 18 confirmed Canavan disease cases and 10 healthy controls.
- Proton magnetic resonance spectroscopy (¹H-MRS) with a TE of 135 ms was used to assess metabolic profiles.
- Specialized software quantified NAA, Cho, and Cr metabolite ratios (NAA/Cr, NAA/Cho) for diagnostic analysis.
Main Results:
- Canavan disease patients exhibited significantly elevated NAA/Cr and NAA/Cho ratios compared to controls (p < 0.001).
- Established diagnostic cutoff values: NAA/Cr of 2.75 and NAA/Cho of 7.18.
- Bootstrap validation yielded an optimism-corrected AUC of 0.96 (95% CI 0.95-1.00), indicating high diagnostic accuracy.
Conclusions:
- This study provides quantitative ¹H-MRS metabolite ratios for Canavan disease diagnosis.
- Preliminary diagnostic thresholds for NAA/Cr and NAA/Cho are proposed to improve diagnostic objectivity.
- This research contributes to a larger single-center cohort evaluating quantitative MRS in Canavan disease.
